Human urinary macrophage colony-stimulating factor reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: A double-blind controlled study

Journal of Clinical Oncology

Volumn 15, Issue 8, 1997, Pages 2954-2965

  Ohno, Ryuzo ^a   Miyawaki, Shuichi ^a   Hatake, Kiyohiko ^a   Kuriyama, Kazutaka ^a   Saito, Kenji ^a   Kanamaru, Akihisa ^a   Kobayashi, Tohru ^a   Kodera, Yoshihisa ^a   Nishikawa, Kiyoshi ^a   Matsuda, Shin ^a   Yamada, Osamu ^a   Omoto, Eijiro ^a   Takeyama, Hideo ^a   Tsukuda, Koji ^a   Asou, Norio ^a   Tanimoto, Mitsune ^a   Shiozaki, Hiroko ^a   Tomonaga, Masao ^a   Masaoka, Tohru ^a   Miura, Yasusada ^a   Takaku, Fumimaro ^a   Ohashi, Yasuo ^a   Motoyoshi, Kazuo ^a   more..

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACLARUBICIN; COLONY STIMULATING FACTOR 1; CYTARABINE; DAUNORUBICIN; METHOTREXATE; MIRIMOSTIM; MITOXANTRONE; PREDNISOLONE; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; THROMBOCYTE TRANSFUSION;

EID: 0030762655     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.8.2954     Document Type: Article

References (70)

1. Ohno R: Current progress in the treatment of adult acute leukemia in Japan. Jpn J Clin Oncol 22:85-97, 1993
2. Mayer RJ, Davis RB, Schiffer CA, et al: Intensive postremission chemotherapy in adults with acute myeloid leukemia. N Engl J Med 331:896-903, 1994
3. Berman E: Chemotherapy in acute myelogenous leukemia: High dose, higher expectations? J Clin Oncol 13:1-4, 1995
4. Larson RA, Dodge RK, Burns CP, et al: A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B study 8811. Blood 85:2025-2037, 1995
5. Gabrilove JL, Jakubowski A, Scher H, et al: Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 318:1414-1422, 1988
6. Ohno R, Tomonaga M, Kobayashi T, et al: Effect of granulocyte colony stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia. N Engl J Med 323:871-877, 1990
7. Crawford J, Ozer H, Stoller R, et al: Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 325:164-170, 1991
8. Brandt SJ, Peters WP, Atwater SK, et al: Effect of recombinant human granulocyte-macrophage colony stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med 318:869-876, 1988
9. Antman KS, Griffin JD, Elias A, et al: Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N Engl J Med 319:593-598, 1988
10. Nemunaitis J, Singer JW, Buckner CD, et al: Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies. Blood 72:834-836, 1988
11. Bettelheim P, Valent P, Andreeff M, et al: Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia. Blood 77:700-711, 1991
12. Motoyoshi K, Ishizaka Y, Miura Y, et al: Clinical application of partially purified human urinary colony-stimulating factor. Immunobiology 172:205-212, 1986
13. Motoyoshi K, Takaku F, Maekawa T, et al: Protective effect of partially purified human urinary colony-stimulating factor on granulocytopenia after antitumor chemotherapy. Exp Hematol 14:1068-1075, 1986
14. Motoyoshi K, Takaku F, Masaoka T, et al: Granulocytopoietic effect of human urinary colony-stimulating factor on prolonged granulocytopenia after cancer chemotherapy (clinical phase III study). J Jpn Soc Cancer Ther 23:2760-2768, 1988
15. Kasamatsu T, Tsunematsu R, Ueda K, et al: The beneficial effect of human urinary colony-stimulating factor (P-100) on recovery from the granulocytopenia after anti-cancer chemotherapy for gynecological cancer. J Jpn Soc Cancer Ther 23:1551-1559, 1988 (in Japanese)
16. Masaoka T, Motoyoshi K, Takaku F, et al: Administration of human urinary colony-stimulating factor after bone marrow transplantation. Bone Marrow Transplant 3:121-127, 1988
17. Masaoka T, Shibata H, Ohno R, et al: Double-blind test of human urinary macrophage colony-stimulating factor for allogeneic and syngeneic bone marrow transplantation: Effectiveness of treatment and 2-year follow-up for relapse of leukaemia. Br J Haematol 76:501-550, 1990
18. Souza LM, Boone TC, Gabrilove JL, et al: Recombinant human granulocyte colony-stimulating factor: Effects on normal and leukemic myeloid cells. Science 232:61-65, 1986
19. Griffin JD, Young D, Herrmann F, et al: Effects of recombinant human GM-CSF on proliferation of clonogenic cells in acute myeloblastic leukemia. Blood 1448-1453, 1986
20. Vellenga E, Ostapovicz D, O'Rourke B, et al: Effects of recombinant IL-3, GM-CSF, and G-CSF on proliferation of leukemic clonogenic cells in short-term and long-term cultures. Leukemia 1:584-589, 1987
21. Begley CG, Nicola NA, Metcalf D: Binding characteristics and proliferative action of purified granulocyte colony-stimulating factor (G-CSF) on normal and leukemic human promyelocytes. Exp Hematol 16:71-79, 1988
22. Suzuki T, Nagata K, Murahashi I, et al: Effect of recombinant human M-CSF on the proliferation of leukemic blast progenitors in AML patients. Leukemia 2:358-362, 1988
23. Miyauchi J, Wang C, Kelleher CA, et al: The effects of recombinant CSF-1 on the blast cells of acute myeloblastic leukemia in suspension culture. J Cell Physiol 135:55-62, 1988
24. Wang C, Kelleher CA, Cheng GYM, et al: Expression of the CSF-1 gene in the blast cells of acute myeloblastic leukemia: Association with reduced growth capacity. J Cell Physiol 135:133-138, 1988
25. Khwaja A, Jones HM, Addison IE, et al: In vivo effects of macrophage colony-stimulating factor on human monocyte function. Br J Haematol 77:25-31, 1991
26. Kayashima S, Tsuru S, Shinomiya N, et al: Effects of macrophage colony-stimulating factor on reduction of viable bacteria and survival of mice during Listeria monocytogenes infection: Characteristics of monocyte subpopulations. Infect Immunol 59:4677-4680, 1991
27. Vitt CR, Fidler FM, Ando D, et al: Antifungal activity of recombinant human macrophage colony-stimulating factor in models of acute and chronic candidiasis in the rat. J Infect Dis 169:369-374, 1994
28. Khwaja A, Yong K, Jones HM, et al: The effect of macrophage colony-stimulating factor on haemopoietic recovery after autologous bone marrow transplantation. Br J Haematol 81:288-295, 1992
29. Hatake K, Izumi T, Imagawa S, et al: Macrophage colony-stimulating factor enhances platelet recovery after chemotherapy. Lancet 342:963, 1993
30. Suzuki M, Ohwada M, Aida I, et al: Macrophage colony-stimulating factor enhances platelet recovery following cisplatin/ carboplatin chemotherapy in ovarian cancer. Gynecol Oncol 54:23-26, 1994
31. Bennett JM, Catovsky D, Daniel MT, et al: Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 103:626-629, 1985
32. Kanamaru A, Takemoto N, Tanimoto M, et al: All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Blood 85:1202-1206, 1995
33. Motoyoshi K: Purification, gene cloning and clinical application of human monocyte specific colony-stimulating factor. Acta Haematol Jpn 50:1557-1564, 1987
34. Freedman L, Sylverster R, Byar DP: Using permutation tests and bootstrap confidence limits to analyze repeated events data from clinical trials. Control Clin Trials 10:129-141, 1989
35. Ohashi Y: Randomization in cancer clinical trials: permutation test and development of a computer program. Environ Health Perspect 87:13-17, 1990
36. Liang K-Y, Zeger SL: Longitudinal data analysis using generalized linear models. Biometrika 73:13-22, 1986
37. Zeger SL, Liang K-Y, Albert PS: Models for longitudinal data: A generalized estimating equation approach. Biometrics 44:1049-1060, 1988
38. Sherr CJ, Rettenmier CW, Sacca R, et al: The c-fms protooncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 41:665-676, 1985
39. Becker S, Warren MK, Haskill S: Colony-stimulating factor induced monocyte survival and differentiation into macrophages in serum free cultures. J Immunol 139:3703-3709, 1987
40. Wang JM, Griffin JD, Ranbaldi A, et al: Induction of monocyte migration by recombinant macrophage colony-stimulating factor. J Immunol 141:575-579, 1988
41. Ralph P, Warren MK, Nakoinz I: Biological properities and molecular biology of the human macrophage growth factor, CSF-1. Immunobiology 172:194-204, 1986
42. Karbassi A, Becker JM, Foster JS, et al: Enhanced killing of Candida albicans by murine macrophages treated with macrophage colony-stimulating factor: Evidence for augmented expression of mannose receptors. J Immunol 139:417-421, 1987
43. Hume DA, Pavli P, Dohahue RE, et al: The effect of human recombinant macrophage colony-stimulating factor (CSF-1) on the murine mononuclear phagocyte system in vivo. J Immunol 141:3405-3409, 1988
44. Ralph P, Nakoinz I: Stimulation of macrophage tumorcidal activity by CSF-1. Cell Immunol 105:270-279, 1987
45. Wing EJ, Ampel NM. Waheed A, et al: Macrophage colony-stimulating factor (M-CSF) enhances the capacity of murine macrophages to secrete oxygen reduction products. J Immunol 135:2052-2056, 1985
46. Mufson RA, Aghajanian J, Wang GG, et al: Macrophage colony-stimulating factor enhances monocyte an macrophage antibody-dependent cell-mediated cytotoxicity. Cell Immunol 119:182-192, 1989
47. Suzu S, Yokota H, Yamada M, et al: Enhancing effect of human monocytic colony-stimulating factor on monocyte tumoricidal activity. Cancer Res 49:5913-5917, 1989
48. Munn DH, Cheung NV: Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor. J Exp Med 78:907-913, 1990
49. Suzu S, Yanai N, Saito M, et al: Enhancement of the antibody-dependent tumoricidal activity of human monocytes by human monocytic colony-stimulating factor. Jpn J Cancer Res 81:79-84, 1990
50. Munn DH, Garnick MB, Cheung NKV: Effects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primates. Blood 75:2042-2048, 1990
51. Komiyama A, Ishiguro A, Kubo T, et al: Increases in neutrophil counts by purified human urinary colony-stimulating factor in chronic neutropenia of childhood. Blood 71:41-45, 1988
52. Nemunaitis J, Meyers JD, Buckner CD, et al: Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections. Blood 78:907-913, 1991
53. Ishizaka Y, Motoyoshi K, Hatake K, et al: Mode of action of human urinary colony-stimulating factor. Exp Hematol 8:1-8, 1986
54. Motoyoshi K, Yoshida K, Hatake K, et al: Recombinant and native urinary colony-stimulating factor directly augments granulocyte and granulocyte-macrophage colony-stimulating factor production of human peripheral blood monocytes. Exp Hematol 17:68-71, 1989
55. Motoyoshi K, Takaku F, Miura Y: High serum colony-stimulating activity of leukocytopenic patients after intravenous infusions of human urinary colony-stimulating factor. Blood 62:685-688, 1983
56. Motoyoshi K, Suda T, Kusumoto K, et al: Granulocyte-macrophage colony-stimulating and binding activities of purified human urinary colony-stimulating factor to murine and human bone marrow cells. Blood 60:1378-1386, 1982
57. Warren MK, Ralph P: Macrophage growth factor-1 stimulates human monocyte production of interferon, tumor necrosis factor and colony-stimulating activity. J Immunol 137:2281-2285, 1986
58. Sakurai T, Suzu S, Yamada M, et al: Induction of tumor necrosis factor in mice by recombinant human macrophage colony-stimulating factor. Jpn J Cancer Res 85:80-85, 1994
59. Hashimoto S, Yoda M, Yamada M, et al: Macrophage colony-stimulating factor induces Interleukin-8 production in human monocyte. Exp Hematol 24:123-128, 1996
60. Kishimoto T, Akira S, Narazaki M, et al: Interleukin-6 family of cytokines and gp30. Blood 86:1243-1254, 1995
61. Hill RJ, Warren MK, Stenberg P, et al: Stimulation of megakaryocytopoiesis in mice by human recombinant interleukin-6. Blood 77:42-48, 1991
62. Yanai N, Yamada M, Motoyoshi K, et al: Effect of human macrophage colony-stimulating factor on granulopoiesis and survival in bone-marrow-transplanted mice. Jpn J Cancer Res 81:355-362, 1990
63. Newman SL, Gootee L: Colony-stimulating factors activate human macrophages to inhibit intracellular growth of Histoplasma capsulatum yeast. Infect Immunol 60:4593-4597, 1992
64. Nemunaitis J, Shannon-Dorcy K, Appelbaum FR, et al: Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor. Blood 82:1422-1427, 1993
65. Ohno R, Naoe T, Kanamaru A, et al: A double-blind controlled study of granulocyte colony-stimulating factor started 2 days before induction chemotherapy in refractory acute myeloid leukemia. Blood 83:2086-2092, 1994
66. Lieschke GJ, Burgess AW: Review article. Granulocyte colony-stimulating factor and granulocyte/macrophage colony-stimulating factor. N Engl J Med 327:28-35, 99-106, 1992
67. Rowe JM, Andersen JW, Mazza JJ, et al: A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: A study of the Eastern Cooperative Oncology Group (E1490). Blood 86:457-462, 1995
68. Ohno R, Tomonaga M, Ohshima T, et al: A randomized controlled study of granulocyte colony-stimulating factor after intensive consolidation therapy in patients with acute lymphoblastic leukemia. Int J Hematol 53:73-81, 1993
69. Takeshita A, Ohno R, Hirashima K, et al: A randomized double-blind controlled study of recombinant human granulocyte colony-stimulating factor in patients with neutropenia induced by consolidation chemotherapy for acute myeloid leukemia. Rinsho Ketsueki 36:606-614, 1995 (in Japanese)
70. Hamada C, Ohashi Y, Ohno R, et al: Statistical analysis of recurrence data for clinical evaluation. Jpn Pharmacol Ther 22:4221-4233, 1994 (in Japanese)